HOSStile STOCKS

[HOSS]

$ENTB $BMSN combo called it on radio early and often last week folks...why?...

$BMSN 10Q filed April 26th, 2012:

NOTE 13. DECONSOLIDATION OF ENTEST BIOMEDICAL, INC.
Effective February 4, 2011 the Company’s ownership of Entest BioMedical, Inc. fell to approximately 49%. and commencing February 4, 2011 the Company’s financial statements reflect the Company’s ownership of Entest under the equity method of accounting. A gain of $42,182,649 was recognized in accordance with ASC 810-10-40-5. Fair value of the Company’s investment in Entest BioMedical, Inc. resulting from deconsolidation was calculated utilizing Level 1 inputs in accordance with ASC 820. As of February 29, 2012 , the end of Entest’s last fiscal quarter, the Company’s ownership of Entest is approximately 38%.

SO $BMSN STRONG OWNERSHIP IN $ENTB ... hmmm

CEO of BOTH $BMSN and $ENTB is ?? ... DAVID KOOS

JUST RECENTLY the $BMSN wholly-owned subsidiary Regen, and now $ENTB, have agreed to financing from Southridge Partners in amounts of $20M and $10M, respectively ... hmmm

BOTH $BMSN and $ENTB ready to roll with stem cell R&D in big ways ... hmmm...

This is by no means all the DD one needs to do, but ties the pieces of a developing puzzle together quite nicely as BOTH stocks have started to heat up in some pretty big ways ... keep in mind these are non-revenue-generating, risky bio stocks that WILL KEEP ON FINANCING as they enter any sort of testing and clinical trials, etc....depending on who holds what and how the financing is structured, these stocks will do what they will...we have all seen some massive runs on these little bios...TRADE smart...lock in some freebies for the potential of one of those runs...don't fall in love...